NO951422L - Farmasöytiske sammensetninger for behandling av osteoporose - Google Patents

Farmasöytiske sammensetninger for behandling av osteoporose

Info

Publication number
NO951422L
NO951422L NO951422A NO951422A NO951422L NO 951422 L NO951422 L NO 951422L NO 951422 A NO951422 A NO 951422A NO 951422 A NO951422 A NO 951422A NO 951422 L NO951422 L NO 951422L
Authority
NO
Norway
Prior art keywords
osteoporosis
treatment
compounds
isokohumulon
cohumulon
Prior art date
Application number
NO951422A
Other languages
English (en)
Other versions
NO951422D0 (no
Inventor
Hiroyasu Tobe
Kazuyuki Kitamura
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of NO951422D0 publication Critical patent/NO951422D0/no
Publication of NO951422L publication Critical patent/NO951422L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

Det blir beskrevet en farmasøytisk sammensetning for behandling av osteoporose, som omfatter som aktivt Ingrediens en effektiv mengde av en eller flere forbindelser valgt fra gruppen omfattende hunmlon, kohumulon, adhumulon, Isohunulon, Isokohumulon og Isoadhumulon l kombinasjon ned en farmasøytisk akseptabel bærer eller ekslplent. Humulon, kohumulon, adhumulon er forbindelser som hører til a-syrer, som er Ingredienser ekstrahert fra humle, mens Isohumulon, Isokohumulon og Isoadumulon er forbindelser som hører til Iso-a-syrederlvater som er Isomerer av a-syrer. De ovenfor beskrevne forbindelsene har en benresorp- sjonshemmende aktivitet, og er nyttige l behandlingen av osteoporose.
NO951422A 1994-04-12 1995-04-11 Farmasöytiske sammensetninger for behandling av osteoporose NO951422L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7323094 1994-04-12

Publications (2)

Publication Number Publication Date
NO951422D0 NO951422D0 (no) 1995-04-11
NO951422L true NO951422L (no) 1995-10-13

Family

ID=13512179

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951422A NO951422L (no) 1994-04-12 1995-04-11 Farmasöytiske sammensetninger for behandling av osteoporose

Country Status (13)

Country Link
US (1) US5604263A (no)
EP (1) EP0677289B1 (no)
KR (1) KR950031059A (no)
AT (1) ATE175575T1 (no)
AU (1) AU696334B2 (no)
CA (1) CA2146820A1 (no)
DE (1) DE69507185T2 (no)
DK (1) DK0677289T3 (no)
ES (1) ES2129691T3 (no)
FI (1) FI951702A (no)
HU (1) HUT71604A (no)
NO (1) NO951422L (no)
TW (1) TW427901B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7901714B2 (en) * 2001-06-20 2011-03-08 Metaproteomics, Llp Treatment modalities for autoimmune diseases
US7718198B2 (en) * 2001-06-20 2010-05-18 Metaproteomics, Llc Treatment modalities for autoimmune diseases
US7901713B2 (en) * 2001-06-20 2011-03-08 Metaproteomics, Llc Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops
US8168234B2 (en) * 2001-06-20 2012-05-01 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US7666449B2 (en) * 2001-06-20 2010-02-23 Metaproteomics, Llc Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
US20040219240A1 (en) * 2001-06-20 2004-11-04 Babish John G. Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
US8142819B2 (en) 2002-10-21 2012-03-27 Metaproteomics, Llc Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
US7205151B2 (en) * 2001-06-20 2007-04-17 Metaproteomics, Llc Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
US8206753B2 (en) * 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
US7270835B2 (en) * 2001-06-20 2007-09-18 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US7279185B2 (en) * 2001-10-26 2007-10-09 Metaproteonics, Llc Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
US20090263522A1 (en) * 2001-10-26 2009-10-22 Babish John G Curcuminoid Compositions Exhibiting Synergistic Inhibition Of The Expression And/Or Activity Of Cyclooxygenase-2
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
KR100993113B1 (ko) * 2002-02-14 2010-11-08 기린 홀딩스 가부시키가이샤 지질대사 개선용 조성물 및 식품
WO2004037180A2 (en) * 2002-10-21 2004-05-06 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
JP2005104951A (ja) * 2003-01-17 2005-04-21 Kirin Brewery Co Ltd 血圧降下用組成物および血管柔軟性改善用組成物並びにこれらの機能が付与された食品
WO2005039483A2 (en) * 2003-05-22 2005-05-06 Metaproteomics, Llc Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
US7914831B2 (en) * 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
US20050192356A1 (en) * 2004-02-27 2005-09-01 Babish John G. Synergistic anti-inflammatory pharmaceutical compositions and methods of use
EP1928248A4 (en) * 2005-08-09 2009-09-16 Metaproteomics Llp MODULATION OF KINASE PROTEINS USING HOP OR ACACIA PRODUCTS
WO2007067812A2 (en) * 2005-12-09 2007-06-14 Metaproteomics, Llc Protein kinase modulation by hops and acacia products
EP2043621A4 (en) * 2006-06-20 2009-08-26 Metaproteomics Llc TREATMENT OF CANCER BY MODULATION OF PROTEIN KINASE USING HEXAHYDRO-ISOALPHA ACIDS
US20080051466A1 (en) * 2006-06-20 2008-02-28 Metaproteomics, Llc Isoalpha acid based protein kinase modulation cancer treatment
AU2008229110A1 (en) * 2007-03-19 2008-09-25 Metaproteomics, Llc Methods and compositions for promoting bone and joint health
CA2686043A1 (en) 2007-05-11 2008-11-20 Metaproteomics, Llc Methods and compositions for heavy metal detoxification
CN101969972A (zh) * 2007-12-10 2011-02-09 麦特普罗泰欧米克斯有限公司 癌症、血管生成、以及与其相关的炎症通路的取代的1,3-环戊二酮多靶点蛋白激酶调节剂
US20100222262A1 (en) * 2008-04-02 2010-09-02 Metaproteomics, Llc Substituted 1, 3-cyclopentadione attenuated endothelial inflammation and endothelial-monocyte interactions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892808A (en) * 1965-11-17 1975-07-01 Carlton & United Breweries Hop extracts
DE1901277A1 (de) * 1969-01-10 1970-08-06 Partipharm Ag Mittel zur Kompensation uebermaessigen Zigarettenkonsums
US5370863A (en) * 1992-12-16 1994-12-06 Miller Brewing Company Oral care compositions containing hop acids and method
JPH06312924A (ja) * 1993-04-28 1994-11-08 Asahi Breweries Ltd 抗酸化作用を有するフムロン類の利用

Also Published As

Publication number Publication date
EP0677289A2 (en) 1995-10-18
US5604263A (en) 1997-02-18
CA2146820A1 (en) 1995-10-13
KR950031059A (ko) 1995-12-18
NO951422D0 (no) 1995-04-11
HU9501043D0 (en) 1995-06-28
EP0677289B1 (en) 1999-01-13
ES2129691T3 (es) 1999-06-16
AU696334B2 (en) 1998-09-10
EP0677289A3 (en) 1996-10-23
TW427901B (en) 2001-04-01
DE69507185T2 (de) 1999-09-09
ATE175575T1 (de) 1999-01-15
FI951702A0 (fi) 1995-04-10
DE69507185D1 (de) 1999-02-25
HUT71604A (en) 1996-01-29
FI951702A (fi) 1995-10-13
DK0677289T3 (da) 1999-09-06
AU1638495A (en) 1995-10-19

Similar Documents

Publication Publication Date Title
NO951422L (no) Farmasöytiske sammensetninger for behandling av osteoporose
BG104544A (en) Novel acylguanadine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
DK0750618T3 (da) Oxazolidinonderivater og farmaceutiske præparater indeholdende dem
TWI256950B (en) Indanyl-substituted benzenecarboxamides, processes for their preparation, their use as a medicament and pharmaceutical formulations containing them
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
MY115339A (en) Compositions containing micronized nebivolol
NZ511903A (en) Use of alpha-keto enamine derivatives as ingredients
YU24402A (sh) 2'-supstituisani 1,1'-bifenil-2-karbonamidi, postupak za njihovu proizvodnju, njihova primena kao leka kao i farmaceutski preparati koji sadrže ta jedinjenja
NO951498L (no) Farmasöytisk preparat for behandling av osteoporose
BG104630A (en) Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
BG104690A (en) Aqueous formulations of parasiticides for skin application
CA2378428A1 (en) Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
MY114944A (en) Propanolamine derivatives, processes for their preparation pharmaceuticals comprising these compounds, and their use
WO2003028475A1 (fr) Aliments pour animaux et engrais renfermant des triterpenes pentacycliques
NO20030417D0 (no) Benzofuranderivater og deres anvendelse som antibakterielle midler
AU3777197A (en) Cyclosporin formulation
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
NO973401L (no) Kortikosteroidinneholdende sammensetninger og fremstilling derav
NO991589L (no) Nye 3-,5- og/eller 6-substituerte analoger av swainsonin, fremgangsmÕter for deres fremstilling og deres anvendelse som terapeutiske midler
MD1762B2 (ro) Derivaţi de pirazoliloxipiridină, procedeu de obţinere a lor, compoziţie erbicidă, procedeu de combatere a plantelor indezirabile
HK1041000B (zh) 新型嘧啶衍生物及其製備方法
NO20022971L (no) Butyndiol-derivater
DK0989994T3 (da) Streptograminderivater, deres fremstilling og præparater, der indeholder dem
ES469020A1 (es) Procedimiento para la preparacion de nuevos 1-acil-2-hidroxi-1,3-diaminopropanos

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application